CG Bio Acquires Majority Stake in Innosys
The acquisition will leverage Innosys' R&D in the spine segment, synergizing with CG Bio's orthobiologic and spinal devices....
Feb 27, 2024,
CG Bio Acquires Majority Stake in Innosys
Systems Thinking Helps Executives Tackle Difficult Decisions
Today’s multifaceted business environment requires executives to implement a structured and predictable approach to decision-making....
Feb 27, 2024,
Enovis Set to Maintain Double-Digit Recon Growth in 2024
The company's orthopedic sales grew in the mid-teens for 2023 and is likely to be a $1 billion recon player...
Feb 26, 2024,
Globus Aims For Integration Steady State by Mid-2024
The company finished 2023 with reported sales growth over 50% as it works to integrate NuVasive and reach a steady...
Feb 22, 2024,
Zimmer Biomet Gains FDA Clearance for ROSA Shoulder System
ROSA Shoulder becomes the first-to-market robotic surgical assistant for shoulder arthroplasty and the fourth ROSA robotics application in five years....
Feb 22, 2024,
Coverage Expansion Continues for Centinel Spine’s prodisc-L
The policy expansion represents 2.3+ million covered lives across Tennessee and includes a positive coverage recommendation for 1- and 2-level...
Feb 21, 2024,
MMI Raises $110 Million in Series C Financing
Symani can support challenging and complex trauma procedures with an increased degree of precision and control in an optimized work...
Feb 21, 2024,
Top 4 Joint Replacement Companies Talk Implants, Techniques at AAOS
The top joint companies used their platforms at AAOS to emphasize that they remain focused on advancing implant, as well...
Feb 21, 2024,
Study Highlights Growing Need to Focus on Sports Injuries in Baby Boomers
The study noted that the types of injuries baby boomers are sustaining are projected to change, providing a call to...
Feb 19, 2024,
Joint Replacement Makes Up For Lost Time in 2023
Backlogged procedures drove much of the robust demand for joint replacement in 2023 but more durable tailwinds could also be...
Feb 16, 2024,
Loading new posts...
No more posts
